Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127073672 | 12707367 | 2 | F | 20160725 | 20160921 | 20160901 | 20160930 | EXP | FR-AFSSAPS-PA20160763 | FR-009507513-1608FRA012122 | MERCK | 68.65 | YR | M | Y | 0.00000 | 20160930 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127073672 | 12707367 | 1 | PS | FORTZAAR 100 MG/12.5 MG COMPRIME PELLICULE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | UNK | Y | 20387 | FILM-COATED TABLET | ||||||||
| 127073672 | 12707367 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | Y | 0 | |||||||||
| 127073672 | 12707367 | 3 | SS | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | UNK | Y | 0 | |||||||||
| 127073672 | 12707367 | 4 | SS | DOXYLAMINE SUCCINATE. | DOXYLAMINE SUCCINATE | 1 | Oral | UNK | Y | 0 | |||||||||
| 127073672 | 12707367 | 5 | SS | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | UNK | Y | 0 | |||||||||
| 127073672 | 12707367 | 6 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | UNK | Y | 0 | |||||||||
| 127073672 | 12707367 | 7 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | UNK | Y | 0 | |||||||||
| 127073672 | 12707367 | 8 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | UNK | U | 0 | |||||||||
| 127073672 | 12707367 | 9 | C | ZESTORETIC | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | 1 TABLET, DAILY, STRENGTH 20/12.5 (UNITS UNSPECIFED) | 0 | 1 | DF | TABLET | QD | |||||||
| 127073672 | 12707367 | 10 | C | BISOPROLOL | BISOPROLOL | 1 | 1.25 MG, DAILY | 0 | 1.25 | MG | QD | ||||||||
| 127073672 | 12707367 | 11 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 15 MG, DAILY | 0 | 15 | MG | TABLET | QD | |||||||
| 127073672 | 12707367 | 12 | C | SERESTA | OXAZEPAM | 1 | 10 MG, THREE TIMES A DAY | 0 | 10 | MG | TID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127073672 | 12707367 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127073672 | 12707367 | Hypoglycaemia | |
| 127073672 | 12707367 | Hypotension | |
| 127073672 | 12707367 | Somnolence | |
| 127073672 | 12707367 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127073672 | 12707367 | 1 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 2 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 3 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 4 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 5 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 6 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 7 | 20160725 | 20160725 | 0 | |
| 127073672 | 12707367 | 8 | 20160725 | 20160725 | 0 |